Download in electronic PDF format for $25



Search the Complete Journal Archives

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease

Author(s):  McElhiney Linda F

Issue:  May/Jun 2012 - Volume 16, Number 3
View All Articles in Issue

Abstract:  Vital dyes have been used for over a hundred years to assist ophthalmic practitioners in diagnosing their patients’ problems. Patients don’t always tolerate the commercial products, usually due to the preservatives, and may need a compounded preparation. Some dyes are not commercially available, such as the brilliant blue G, and compounders who specialize in high-risk compounded sterile preparations are needed to meet these needs of the ophthalmologists. This article discusses some of these staining agents, including their properties.

Related Keywords: Linda F. McElhiney, PharmD, RPh, FIACP, FASHP, FACA, vital dyes, ophthalmic stains, ocular pathology, eye disorders, formulations, cornea lesions, corneal abrasions, keratitis, preservatives, compounded sterile preparations, microbial contamination, ophthalmic solutions, fluorescein, rose bengal, dry eye, keratoconjunctivitis sicca, lissamine green B, brilliant blue G, intravitreal administration

Related Categories: FORMULATIONS, OPHTHALMICS, STERILE PREPARATIONS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease McElhiney Linda F May/Jun 2012 190-195 Buy
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Allen Loyd V Jr Sep/Oct 2016 399-404 Buy
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Mixon William, Angelle Patricea (Patsy), Chang Richard I Nov/Dec 2009 506-515 Buy
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Allen Loyd V Jr Nov/Dec 2016 495-500 Buy
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations McElhiney Linda F Jul/Aug 2013 307-311 Buy
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together McElhiney Linda F Jul/Aug 2010 270-274 Buy
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole Nov/Dec 2009 540-543 Buy
Compounding for Feline Herpetic Keratitis Davidson Gigi S Nov/Dec 2006 411-414 Buy
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc Jan/Feb 2014 6-12 Buy
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Allen Loyd V Jr Sep/Oct 2010 421 Buy